Safety and early efficacy analysis of a novel combination of the PARP inhibitor veliparib (ABT-888) plus bendamustine and rituximab in patients with lymphoma Meeting Abstract

  

Authors:	Gerecitano, J. F.; Hamlin, P.; Horwitz, S. M.; Matasar, M. J.; Moskowitz, A. J.; Moskowitz, C. H.; Noy, A.; Portlock, C. S.; Palomba, M. L.; Straus, D. J.; Younes, A.; Zelenetz, A. D.; Chen, A.; Little, R. F.; Fallon, F.; Whang, J. H.
Abstract Title:	Safety and early efficacy analysis of a novel combination of the PARP inhibitor veliparib (ABT-888) plus bendamustine and rituximab in patients with lymphoma
Meeting Title:	56th Annual Meeting of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	124
Issue:	21
Meeting Dates:	2014 Dec 6-9
Meeting Location:	San Francisco, CA
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2014-12-06
Language:	English
ACCESSION:	WOS:000349242704065
PROVIDER:	wos
Notes:	Meeting Abstract: 1739 -- Source: Wos